United Therapeutics Corporation
UTHR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $339 | $310 | $322 | $301 |
| Dep. & Amort. | $22 | $21 | $20 | $20 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $38 | $32 | $27 |
| Change in WC | $163 | -$203 | $78 | -$4 |
| Other Non-Cash | $39 | $26 | $9 | -$3 |
| Operating Cash Flow | $562 | $192 | $461 | $341 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$211 | -$62 | -$75 | -$87 |
| Net Acquisitions | $0 | $0 | $0 | -$30 |
| Inv. Purchases | -$416 | -$1,807 | -$692 | -$479 |
| Inv. Sales/Matur. | $183 | $1,570 | $612 | $478 |
| Other Inv. Act. | $585 | -$1 | -$9 | -$6 |
| Investing Cash Flow | $141 | -$300 | -$165 | -$123 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$212 | -$100 | -$100 |
| Stock Issued | $45 | $18 | $0 | $0 |
| Stock Repurch. | -$1,000 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$5 | $6 | $26 |
| Financing Cash Flow | -$956 | -$199 | -$94 | -$75 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$253 | -$307 | $203 | $143 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,593 | $1,900 | $1,697 | $1,554 |
| End Cash | $1,340 | $1,593 | $1,900 | $1,697 |
| Free Cash Flow | $352 | $130 | $386 | $255 |